Clinical research of compound Zhebei granules for increasing the therapeutic effect of chemotherapy in refractory acute leukemia patients

Journal of Traditional Chinese Medicine

Volumn 29, Issue 3, 2009, Pages 190-194

  Lu, Dian Rong ^a   Li, Dong Yun ^a   Chen, Xin Yi ^a   Ye, Pei Zhi ^a   Tian, Shao Dan ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Compound Zhebei granules (CZG); Refractory acute leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; FRITILLARIAE THUNBERGII EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; PLACEBO; PLANT EXTRACT; STEPHANIAE TETRANDRAE EXTRACT; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLANT BULB; PLANT ROOT; RANDOMIZED CONTROLLED TRIAL; RHIZOME; THERAPY EFFECT;

EID: 70449130833     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(09)60063-7     Document Type: Article

References (12)

1. Yao EG. The treatment tactics for refractory leukemia. Journal of Leukemia & Lymphoma 2003; 12:173-175.
2. Zhang ZN. Diagnosis of hematopathy and standards for evaluation of the therapeutic effect. Tianjin: Tianjin Science and Technology Publishing House 1991; 190-218.
3. Li DY, Chen XY, Liu RJ. A review on basic studies of compositions of single Chinese drug for reversing multidrug resistance of leukemia. Chinese Journal of Information on TCM 2004; 11: 951-953.
4. Hu KW, Zheng HX, Qi JG, et al. A research on peimine for reversing multidrug resistance of leukemia cells. Chinese Journal of Hematology 1999; 20: 650-651.
5. Xu WL, Jiang YW, Wang FC, et al. Study on the mechanism of tetrandrine in reversing multidrug resistance of leukemia cell line K562/ADM. Practical Journal of Cancer 2003; 18: 349-351.
6. Liang R, Yang PD, Chen XQ. Study on ligustrazine in reversing multidrug resistance of leukemia cell line HL60/VCR and the mechanism. Chinese Journal of Hematology 1999; 20: 324-326.
7. Li JH, Yang PM. Study on ligustrazine in reversing multidrug resistance of K562/ADM cell. Modern Journal Integrated Traditional and Western Medicine 2001; 10: 1405-1407.
8. Li W, Hu KW, Su W. Clinical trial of Zhe Bei Mu powder for reversing multidrug resistance in the patients with acute leukemia. Journal of Beijing University of Chinese Medicine 2004; 27: 65-67.
9. Li DY, Ye PZ, Tian SD, et al. Clinical observation on the therapeutic effect of Zhe Bei and its formula granule for refractory acute leukemia. Journal of Traditional Chinese Medicine 2006; 24: 1449-1450.
10. Xu WL, Ao ZF, Chen BA. Clinical research of tetrandrine for reversing multidrud resistance of tumor cells in hematological system. Chinese Journal of Internal Medicine 2001; 40: 633-635.
11. Zhao YC, Chen XY, Xu YM, et al. Preliminary clinical study on Ligustrazine for reversing the multi-drug resistance of acute leukemia. Chinese Journal of Information on Traditional Chinese Medicine 2003; 10: 10-12.
12. Li DY, Chen XY. Current situation of the studies on Zhe Bei Mu and discussion on the prospects of its clinical application. Chinese Clinical Journal of Integrated Chinese and Western Medicine 2006; 6: 629-632.